Business / Finance

RSS

China Nepstar Chain Drugstore third quarter revenue increases 1.9% to RMB608.6 million

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2011.

28 Nov 2011

Cardinal Health Canada, Futuremed report on proposed acquisition

Futuremed Healthcare Products Corporation and Cardinal Health Canada Inc., a wholly-owned subsidiary of Cardinal Health, Inc., reported on developments in the Competition Bureau's review of Cardinal Health Canada's proposed acquisition of Futuremed under the Canadian Competition Act.

25 Nov 2011

RaySearch reports net sales of SEK 80.3 M for JANUARY 1 – SEPTEMBER 30, 2011

RaySearch Laboratories: JANUARY 1 - SEPTEMBER 30, 2011. Net sales for the period totaled SEK 80.3 M.

24 Nov 2011

Pfizer enters definitive agreement to acquire Excaliard

Pfizer Inc. and Excaliard Pharmaceuticals, Inc. announced today that they have entered into a definitive agreement under which Pfizer will acquire Excaliard, a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring. The acquisition is expected to close before the end of the year.

22 Nov 2011

UnitedHealthcare announces agreement to acquire XLHealth

UnitedHealthcare, a UnitedHealth Group company, has agreed to acquire XLHealth Corp., a sponsor of Medicare Advantage health plans with a primary focus on Medicare recipients with special needs, such as those with chronic illness, and those also eligible for Medicaid.

22 Nov 2011

TRIGOcare, Systagenix partner to deliver wound care products

In a pressed economic climate, the estimated 3 million chronic wounds treated every year costs the German health care system several billion Euros, a situation fuelled by an annual prevalence of 650,000 new patients. This creates an immense cost pressure on everyone involved in wound care, in a market already characterised by tough competition, ever changing political framework and an expectation of innovation and improved quality of care.

22 Nov 2011

CHRI third quarter revenues increase 219% to $9.3 million

China Health Resource, Inc., a producer and supplier of Traditional Chinese Medicine (TCM) products, announced robust record breaking quarterly earnings for September 2011.

22 Nov 2011

MIT, Pfizer announce new location for CVMED and Neuroscience research units

Pfizer Inc. and the Massachusetts Institute of Technology (MIT) today held the official groundbreaking of the new location of Pfizer's Cardiovascular, Metabolic and Endocrine Diseases (CVMED) and Neuroscience research units at 610 Main Street, Cambridge, MA.

22 Nov 2011

Roche establishes strategic alliance with Cedars-Sinai Medical Center

Roche announced today the establishment of a strategic alliance with Cedars-Sinai Medical Center in Los Angeles for the center to operate as a Roche Molecular Center of Excellence (MCOE) for the next five years.

From Roche Sequencing and Life Science 21 Nov 2011

Phototron third quarter revenue increases 127%

Phototron Holdings, Inc., the designer, manufacturer and seller of the innovative PHOTOTRON Hydroponic Indoor Grow System, today announced the availability of its third quarter 2011 financial results for the period ending September 30, 2011.

21 Nov 2011

Despite market constraints, the drug market for key hospital-treated infections will increase: Report

Decision Resources finds that the drug market for key hospital-treated infections that are of high interest to drug developers—most notably nosocomial pneumonia, bloodstream infections, skin and skin structure/surgical site infections and urinary tract infections—will increase from $3.3 billion in 2010 to just over $4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

21 Nov 2011

The Chinese acute coronary syndrome drug market to grow from $326M in 2010 to $448M in 2015

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the acute coronary syndrome (ACS) drug market in China will grow from $326 million in 2010 to $448 million in 2015.

21 Nov 2011

Safeguard board renews prior authorization of share repurchase program

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that its Board of Directors has renewed its prior authorization of a share repurchase program.

21 Nov 2011

Covidien to acquire BÂRRX Medical

Covidien, a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett's esophagus syndrome using bipolar radiofrequency (RF) ablation devices.

21 Nov 2011

Cigna, HealthSpring receive early termination of waiting period under Hart-Scott-Rodino Act

Cigna Corporation and HealthSpring, Inc. today announced that they have received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with Cigna's pending acquisition of HealthSpring. The early termination of the waiting period under the Hart-Scott-Rodino Act satisfies one of the conditions for consummation of the transaction.

21 Nov 2011

ChanRx to evaluate AFIB drug, vanoxerine with closed Series A funding

ChanRx is developing a superior drug for treatment of atrial fibrillation (AFIB), and has closed its Series A funding with investments from Sante Ventures and company founder, Dr. Arthur "Buzz" Brown. The company, a spin out of Cleveland-based ChanTest, will use the funding to further evaluate the safety and efficacy of its proprietary AFIB drug, vanoxerine.

21 Nov 2011

Medizone, SMTC enter partnership to manufacture AsepticSure disinfection system

Medizone International, a leading-edge research and development company that specializes in decontamination and sterilization systems and SMTC Corporation, a global electronics manufacturing services provider, today jointly announce a new partnership agreement to manufacture Medizone's AsepticSure disinfection system.

21 Nov 2011

WaferGen third quarter revenue decreases to $89,000

WaferGen Biosystems, Inc., an emerging genomic analysis company, today reported financial results for the three and nine months ended September 30, 2011 and announced a revised plan to commercialize and increase adoption of its SmartChip System.

21 Nov 2011

Aetna, Banner Health Network enter accountable care collaboration

Aetna today announced an accountable care collaboration with Banner Health Network and the introduction of Aetna Whole Health, a new commercial health care product that provides members access to highly coordinated care from physicians and facilities in the Banner Health Network.

21 Nov 2011

BioSante listed on NASDAQ Biotechnology Index

BioSante Pharmaceuticals, Inc. today announced that it has been added to the NASDAQ Biotechnology Index, effective prior to the stock market open today, November 21, 2011.

21 Nov 2011